Sophia Genetics
SOPH
6.92
-0.23
-3.22%
Sophia Genetics
US · SOPH
#3618 by market cap
Listed 2021
6.92
-0.23
-3.22%
Live - 5344 symbols - heartbeat 249s ago
· 2026-10-08 09:58
Pre-market
7.15
0.00%
After-hours
7.15
0.00%
Overnight
7.15
0.00%
- Market cap
- 589.08M
- P/E (TTM)i
- -5.97
- P/Bi
- 7.09
- EPSi
- -1.17
- Div yieldi
- 0.00%
- 52W posi
- 61%
Reader sentiment
Are you bullish or bearish on SOPH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -2.01, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +18.56% YoY
Margins
- Gross margin
- 67.40%
- Operating margin
- -91.76%
- Net margin
- -102.24%
Key ratios & quality
- Enterprise valuei
- 569.23M
- Altman Z-Scorei
- -2.01
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | 25.36M | 28.40M | 40.45M | 47.56M | 62.37M | 65.17M | 77.27M |
| Gross profit | -- | 17.83M | 17.69M | 25.22M | 31.25M | 42.91M | 43.94M | 52.08M |
| Selling & admin expenses | -- | 35.08M | 36.40M | 70.24M | 84.08M | 77.98M | 73.21M | 86.07M |
| Research & development | -- | 15.02M | 18.59M | 26.58M | 35.37M | 36.97M | 34.37M | 34.22M |
| Operating profit | -- | -32.29M | -37.39M | -71.49M | -87.82M | -74.83M | -66.57M | -70.91M |
| Pretax profit | -- | -33.63M | -41.23M | -73.51M | -87.59M | -78.50M | -61.27M | -77.49M |
| Tax | -- | 162.00K | -1.89M | 168.00K | -136.00K | 486.00K | 1.22M | 1.51M |
| Net profit | -- | -33.79M | -39.34M | -73.68M | -87.45M | -78.98M | -62.49M | -79.00M |
| Basic EPS | -- | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| Diluted EPS | -- | -0.70 | -0.82 | -1.33 | -1.36 | -1.22 | -0.95 | -1.17 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 17.78M | 18.32M | 19.46M | 21.71M | 21.69M | 23.31M |
| Gross profit | 12.21M | 12.27M | 12.91M | 14.69M | 14.75M | 15.06M |
| Selling & admin expenses | 19.13M | 22.34M | 22.56M | 22.04M | 22.57M | 26.39M |
| Research & development | 9.12M | 8.49M | 8.07M | 8.54M | 9.46M | 8.73M |
| Operating profit | -16.04M | -18.49M | -17.86M | -18.52M | -17.28M | -20.05M |
| Pretax profit | -16.88M | -21.65M | -19.38M | -19.57M | -19.07M | -22.28M |
| Tax | 503.00K | 762.00K | 642.00K | -395.00K | 253.00K | 78.00K |
| Net profit | -17.39M | -22.41M | -20.02M | -19.18M | -19.32M | -22.36M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.26 | -0.33 | -0.30 | -0.28 | -0.27 | -0.30 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 62.72M | 33.76M | 109.69M | 282.86M | 196.26M | 148.05M | 99.41M | 99.08M |
| Cash & ST investments | 54.32M | 18.44M | 97.35M | 265.32M | 178.61M | 123.25M | 80.23M | 70.29M |
| Inventory | 2.87M | 3.61M | 3.38M | 5.73M | 5.16M | 6.48M | 5.87M | 6.35M |
| Total assets | 76.62M | 51.66M | 132.12M | 320.17M | 243.84M | 206.16M | 155.31M | 163.03M |
| Total current liabilities | 11.40M | 19.26M | 21.59M | 28.60M | 26.81M | 35.62M | 26.80M | 50.53M |
| Short-term debt | 2.49M | 3.19M | 3.91M | 1.81M | 2.69M | 2.93M | 2.19M | 2.70M |
| Long-term debt | 3.91M | 1.61M | 457.00K | -- | -- | -- | 13.24M | 47.73M |
| Total liabilities | 21,803,000.00 | 29,402,000.00 | 31,605,000.00 | 44,773,000.00 | 43,708,000.00 | 54,714,000.00 | 58,819,000.00 | 115,886,000.00 |
| Total equity | 54.82M | 22.25M | 100.51M | 275.40M | 200.13M | 151.44M | 96.49M | 47.15M |
| Retained earnings | -64.55M | -98.34M | -137.68M | -211.35M | -298.80M | -377.78M | -440.28M | -519.28M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 90.05M | 117.03M | 103.48M | 99.08M | 95.81M | 137.29M |
| Cash & ST investments | 68.53M | 94.82M | 81.61M | 70.29M | 65.39M | 107.67M |
| Inventory | 5.05M | 6.22M | 6.68M | 6.35M | 7.09M | 7.08M |
| Total assets | 146.72M | 177.62M | 163.46M | 163.03M | 157.00M | 198.36M |
| Total current liabilities | 28.94M | 34.49M | 36.93M | 50.53M | 46.60M | 51.08M |
| Short-term debt | 2.29M | 2.49M | 2.61M | 2.70M | 2.71M | 2.72M |
| Long-term debt | 13.32M | 47.47M | 47.58M | 47.73M | 47.84M | 48.00M |
| Total liabilities | 61,106,000.00 | 100,928,000.00 | 102,771,000.00 | 115,886,000.00 | 111,307,000.00 | 115,241,000.00 |
| Total equity | 85.61M | 76.69M | 60.69M | 47.15M | 45.69M | 83.12M |
| Retained earnings | -457.66M | -480.08M | -500.10M | -519.28M | -538.60M | -560.95M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -- | -31.68M | -31.73M | -57.94M | -70.09M | -53.22M | -44.52M | -35.89M |
| Depreciation & amortization | -- | 1.91M | 2.39M | 3.61M | 5.57M | 8.34M | 8.60M | 9.53M |
| Free cash flow | -- | -34.71M | -34.93M | -64.61M | -80.47M | -62.45M | -52.69M | -44.51M |
| Dividends paid | -- | -- | -- | -- | -- | 0 | 0 | 0 |
| Stock buybacks / issuance | -- | 0 | 107.64M | 231.31M | -- | 0 | 0 | 1.09M |
| Ending cash balance | -- | 18.07M | 74.63M | 192.96M | 161.31M | 123.25M | 80.23M | 70.29M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -10.75M | -8.21M | -8.79M | -8.14M | -15.12M | -7.69M |
| Depreciation & amortization | 2.30M | 2.37M | 2.42M | 2.44M | 2.75M | 2.91M |
| Free cash flow | -12.24M | -10.19M | -11.48M | -10.60M | -17.99M | -10.39M |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock buybacks / issuance | 0 | 0 | -- | -- | 14.50M | 55.22M |
| Ending cash balance | 68.53M | 94.82M | 81.61M | 70.29M | 65.39M | 107.67M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -87.69 | -64.09 | -39.20 | -36.78 | -44.93 | -50.41 | -110.00 |
| ROA %i | -- | -52.68 | -42.81 | -32.58 | -31.01 | -35.10 | -34.58 | -49.63 |
| ROIC %i | -- | -70.03 | -55.79 | -36.95 | -34.88 | -42.36 | -42.88 | -65.05 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -54.54 | -47.08 | -56.26 |
| EBIT margin %i | -- | -128.75 | -142.20 | -180.10 | -182.81 | -124.91 | -91.08 | -94.39 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 5.50 | 1.75 | 5.08 | 9.89 | 7.32 | 4.16 | 3.71 | 1.96 |
| Quick ratioi | 5.21 | 1.46 | 4.87 | 9.52 | 6.96 | 3.89 | 3.32 | 1.72 |
| Debt / assetsi | 12.03 | 16.39 | 5.49 | 4.08 | 6.87 | 9.02 | 19.34 | 38.66 |
| LT debt / equityi | 12.27 | 23.69 | 3.32 | 4.08 | 7.02 | 10.35 | 28.85 | 127.95 |
| Interest coveragei | -- | -33.46 | -48.08 | -110.71 | -136.07 | -132.49 | -31.03 | -16.02 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | 23.32 | 29.98 | 17.23 | 17.56 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -60.75 | -74.09 | -86.09 | -110.00 | -123.28 | -101.22 |
| ROA %i | -40.48 | -40.92 | -43.97 | -49.63 | -53.30 | -43.02 |
| ROIC %i | -50.14 | -50.21 | -54.91 | -65.05 | -69.73 | -53.99 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -92.80 | -98.86 | -93.99 | -94.39 | -91.29 | -85.50 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 3.11 | 3.39 | 2.80 | 1.96 | 2.06 | 2.69 |
| Quick ratioi | 2.74 | 3.03 | 2.44 | 1.72 | 1.71 | 2.38 |
| Debt / assetsi | 20.54 | 35.93 | 38.77 | 38.66 | 39.76 | 31.17 |
| LT debt / equityi | 32.52 | 79.97 | 100.13 | 127.95 | 130.70 | 71.11 |
| Interest coveragei | -25.66 | -27.70 | -19.34 | -16.02 | -13.32 | -11.12 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 09:58:23 · For reference only, not investment advice and not tailored to your situation.